Photo from wikipedia
The treatment of hepatitis C (HCV) with interferon (IFN)‐free direct‐acting antivirals (DAAs) is anticipated to change the future burden of disease. The aim of this study is to quantify the… Click to show full abstract
The treatment of hepatitis C (HCV) with interferon (IFN)‐free direct‐acting antivirals (DAAs) is anticipated to change the future burden of disease. The aim of this study is to quantify the impact of IFN‐free DAAs on HCV‐related morbidity and mortality in Greece under different scenarios concerning treatment coverage and primary prevention, including the proposed by World Health Organization Global Hepatitis Strategy.
Keywords:
possible country;
country low;
hcv;
hcv possible;
elimination hcv;
low diagnostic
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!